SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-068949
Filing Date
2021-12-10
Accepted
2021-12-10 11:27:09
Documents
2
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4884
2 EX-24 DOCUMENT attachment1.htm EX-24 3482
  Complete submission text file 0001209191-21-068949.txt   9765
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
KELLY JUSTYNA (Reporting) CIK: 0001898344 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39373 | Film No.: 211484334